GLOMERULAR FILTRATION RATE PROFILES IN PAEDIATRIC PATIENTS ON CANCER CHEMOTHERAPY AT THE KENYATTA NATIONAL HOSPITAL, KENYA
- PMID: 26845811
GLOMERULAR FILTRATION RATE PROFILES IN PAEDIATRIC PATIENTS ON CANCER CHEMOTHERAPY AT THE KENYATTA NATIONAL HOSPITAL, KENYA
Abstract
Background: An accurate estimation of renal function in children is important in optimising the dose of many drugs used in paediatric oncology for allowing clinical monitoring of the nephrotoxic effects of cytotoxic agents such as cisplatin. The glomerular filtration rate (GFR) is widely accepted as the best index of renal function in patients. Chemotherapy is the mainstay of treatment in the paediatric oncology unit at the Kenyatta National Hospital.
Objectives: To determine the glomerular filtration rate profiles of paediatric oncology patients and to assess changes that had occured over a period of at least six months of continuing cancer chemotherapy.
Design: Cross-sectional hospital based survey.
Setting: General Paediatric wards, including Paediatric Oncology and Paediatric Ophthalmology ward. Kenyatta National Hospital, Nairobi, Kenya. Subjects: Paediatric patients who had an established diagnosis of cancer and had been on chemotherapy for at least six months.
Results: Out of the 115 children enrolledin the study 43 had abnormal kidney function, This gave a prevalence of 37% (95% CI 28-46).The other 72 children had normal kidney function. Patients aged less than five years and those with solid tumors had a higher likelihood of having an abnormal GFR compared to their older counterparts and thosc with-lymphomas and leukemias.
Conclusions: Monitoring of GFR should be done regularly as decline occurs as one continues on chemotherapy especially for the ones below five years and those witl solid malignancies.
Similar articles
-
[The kidney in children under chemotherapy].Rev Med Suisse Romande. 1996 Dec;116(12):985-93. Rev Med Suisse Romande. 1996. PMID: 9026889 Review. French.
-
Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: relevance of age and dose as risk factors.Eur J Cancer. 2009 Dec;45(18):3213-9. doi: 10.1016/j.ejca.2009.06.032. Epub 2009 Oct 21. Eur J Cancer. 2009. PMID: 19850470
-
Ifosfamide-induced nephrotoxicity in 593 sarcoma patients: a report from the Late Effects Surveillance System.Pediatr Blood Cancer. 2007 Apr;48(4):447-52. doi: 10.1002/pbc.20858. Pediatr Blood Cancer. 2007. PMID: 16628552
-
Nephrotoxicity following carboplatin use in children: is routine monitoring of renal function necessary?Med Pediatr Oncol. 1993;21(1):31-5. doi: 10.1002/mpo.2950210107. Med Pediatr Oncol. 1993. PMID: 8426573
-
Assessment and management of renal impairment in chemotherapy for urogenital cancer.Jpn J Clin Oncol. 2013 Nov;43(11):1055-63. doi: 10.1093/jjco/hyt132. Epub 2013 Sep 12. Jpn J Clin Oncol. 2013. PMID: 24031085 Review.
Cited by
-
Chemotherapy-Induced Electrolyte Disorder and Nephrotoxicity in Cancer Patients from Selected Nigerian Tertiary Health Care Hospitals.Niger Med J. 2022 Sep 12;63(3):196-203. doi: 10.60787/NMJ-63-3-102. eCollection 2022 May-Jun. Niger Med J. 2022. PMID: 38835537 Free PMC article.
-
Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer.Cochrane Database Syst Rev. 2019 Mar 11;3(3):CD008944. doi: 10.1002/14651858.CD008944.pub3. Cochrane Database Syst Rev. 2019. PMID: 30855726 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical